3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide

C122H136Br3F8I2N15O5 — CID 159135995

IUPAC3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide
SMILESCC(C)CCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1.CCCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1
InChIInChI=1S/2C25H28BrF2N3O.C24H26BrF2N3O.2C24H27FIN3O/c1-16(2)11-12-30(25(32)17-7-9-21(28)20(26)13-17)15-24-29-22-14-18(27)8-10-23(22)31(24)19-5-3-4-6-19;1-2-3-6-13-30(25(32)17-9-11-21(28)20(26)14-17)16-24-29-22-15-18(27)10-12-23(22)31(24)19-7-4-5-8-19;1-15(2)13-29(24(31)16-7-9-20(27)19(25)11-16)14-23-28-21-12-17(26)8-10-22(21)30(23)18-5-3-4-6-18;1-16(2)14-28(24(30)17-6-5-7-19(26)12-17)15-23-27-21-13-18(25)10-11-22(21)29(23)20-8-3-4-9-20;1-2-3-13-28(24(30)17-7-6-8-19(26)14-17)16-23-27-21-15-18(25)11-12-22(21)29(23)20-9-4-5-10-20/h7-10,13-14,16,19H,3-6,11-12,15H2,1-2H3;9-12,14-15,19H,2-8,13,16H2,1H3;7-12,15,18H,3-6,13-14H2,1-2H3;5-7,10-13,16,20H,3-4,8-9,14-15H2,1-2H3;6-8,11-12,14-15,20H,2-5,9-10,13,16H2,1H3
InChIKeyKHMPECPNVSELAK-UHFFFAOYSA-N
MW2538.03 g/mol
LogP32.93
Rot. Bonds34

About 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide

3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide (PubChem CID 159135995) has the molecular formula C122H136Br3F8I2N15O5 and a molecular weight of 2538.03 g/mol. Its IUPAC name is 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide.

Molecular Properties

Compound Name3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide
PubChem CID159135995
Molecular FormulaC122H136Br3F8I2N15O5
Molecular Weight2538.03 g/mol
Exact Mass2533.64
IUPAC Name3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide
SMILESCC(C)CCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1.CCCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1
InChIInChI=1S/2C25H28BrF2N3O.C24H26BrF2N3O.2C24H27FIN3O/c1-16(2)11-12-30(25(32)17-7-9-21(28)20(26)13-17)15-24-29-22-14-18(27)8-10-23(22)31(24)19-5-3-4-6-19;1-2-3-6-13-30(25(32)17-9-11-21(28)20(26)14-17)16-24-29-22-15-18(27)10-12-23(22)31(24)19-7-4-5-8-19;1-15(2)13-29(24(31)16-7-9-20(27)19(25)11-16)14-23-28-21-12-17(26)8-10-22(21)30(23)18-5-3-4-6-18;1-16(2)14-28(24(30)17-6-5-7-19(26)12-17)15-23-27-21-13-18(25)10-11-22(21)29(23)20-8-3-4-9-20;1-2-3-13-28(24(30)17-7-6-8-19(26)14-17)16-23-27-21-15-18(25)11-12-22(21)29(23)20-9-4-5-10-20/h7-10,13-14,16,19H,3-6,11-12,15H2,1-2H3;9-12,14-15,19H,2-8,13,16H2,1H3;7-12,15,18H,3-6,13-14H2,1-2H3;5-7,10-13,16,20H,3-4,8-9,14-15H2,1-2H3;6-8,11-12,14-15,20H,2-5,9-10,13,16H2,1H3
InChIKeyKHMPECPNVSELAK-UHFFFAOYSA-N
XLogP32.93
TPSA190.65 Ų
H-Bond Donors
H-Bond Acceptors15
Rotatable Bonds34
Heavy Atoms155
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002538.03
LogP ≤ 532.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide?
The IUPAC name of 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide (CID 159135995) is 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide.
What is the SMILES notation for 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide?
The canonical SMILES for 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide is CC(C)CCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CC(C)CN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1.CCCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1ccc(F)c(Br)c1.CCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cccc(I)c1.
What is the InChIKey of 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide?
The InChIKey is KHMPECPNVSELAK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H28BrF2N3O.C24H26BrF2N3O.2C24H27FIN3O/c1-16(2)11-12-30(25(32)17-7-9-21(28)20(26)13-17)15-24-29-22-14-18(27)8-10-23(22)31(24)19-5-3-4-6-19;1-2-3-6-13-30(25(32)17-9-11-21(28)20(26)14-17)16-24-29-22-15-18(27)10-12-23(22)31(24)19-7-4-5-8-19;1-15(2)13-29(24(31)16-7-9-20(27)19(25)11-16)14-23-28-21-12-17(26)8-10-22(21)30(23)18-5-3-4-6-18;1-16(2)14-28(24(30)17-6-5-7-19(26)12-17)15-23-27-21-13-18(25)10-11-22(21)29(23)20-8-3-4-9-20;1-2-3-13-28(24(30)17-7-6-8-19(26)14-17)16-23-27-21-15-18(25)11-12-22(21)29(23)20-9-4-5-10-20/h7-10,13-14,16,19H,3-6,11-12,15H2,1-2H3;9-12,14-15,19H,2-8,13,16H2,1H3;7-12,15,18H,3-6,13-14H2,1-2H3;5-7,10-13,16,20H,3-4,8-9,14-15H2,1-2H3;6-8,11-12,14-15,20H,2-5,9-10,13,16H2,1H3.
What are the key properties of 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide?
3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide has a molecular weight of 2538.03 g/mol, XLogP of 32.93, 34 rotatable bonds, 0 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(3-methylbutyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-(2-methylpropyl)benzamide;3-bromo-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-4-fluoro-N-pentylbenzamide;N-butyl-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodobenzamide;N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-3-iodo-N-(2-methylpropyl)benzamide is sourced from PubChem (CID 159135995), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).